Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Opioid Use Disorder Topic Center

Featured Article

News
Methadone Access Reform Needed to Address the US Opioid Crisis
03/08/2024

Emry Lloyd

Emry Lloyd
As the overdose crisis intensifies, US federal regulations must undergo necessary revisions, ensuring access to life-saving medications and aligning with standards set by other advanced nations.
As the overdose crisis intensifies, US federal regulations must undergo necessary revisions, ensuring access to life-saving medications and aligning with standards set by other advanced nations.
As the overdose crisis...
03/08/2024
Pharmacy Learning Network
Quiz
Calculating the Global Scope of OUD
12/05/2023
How many people experience opioid use disorder (OUD) globally?
How many people experience opioid use disorder (OUD) globally?
How many people experience...
12/05/2023
Pharmacy Learning Network
News
Navigating the Opioid Epidemic: Research Insights, the DSM-5, and the Mainstreaming Addiction Treatment Act
12/04/2023
"While opioid use disorder is on the rise across the world and has transformed into an epidemic in the US, it needs a better understanding from health care professionals and government intervention along with resources and a team-based...
"While opioid use disorder is on the rise across the world and has transformed into an epidemic in the US, it needs a better understanding from health care professionals and government intervention along with resources and a team-based...
"While opioid use disorder is on...
12/04/2023
Pharmacy Learning Network
Quiz
True or False: Unlawful Opioid Distribution Statistics
12/01/2023
True or False: The DOJ’s Health Care Fraud Strike Force, operating since March 2007, has charged more than 5000 defendants who collectively billed federal health care programs and private insurance companies close to $28 billion.
True or False: The DOJ’s Health Care Fraud Strike Force, operating since March 2007, has charged more than 5000 defendants who collectively billed federal health care programs and private insurance companies close to $28 billion.
True or False: The DOJ’s Health...
12/01/2023
Pharmacy Learning Network
News
Crucial Research Funding: Unveiling Strategies to Combat Widespread and Deadly Addictions in the US
11/22/2023
Sanford Burnham Prebys researchers have secured federal grants totaling almost $25 million to propel their investigations and clinical trials aimed at understanding and treating addiction.
Sanford Burnham Prebys researchers have secured federal grants totaling almost $25 million to propel their investigations and clinical trials aimed at understanding and treating addiction.
Sanford Burnham Prebys...
11/22/2023
Pharmacy Learning Network
Quiz
Long-Term Pain Management With Opioids
11/22/2023
True or False: Opioids are effective long-term pain medications.
True or False: Opioids are effective long-term pain medications.
True or False: Opioids are...
11/22/2023
Pharmacy Learning Network
News
Understanding the Opioid Epidemic: Diagnosis, Risk Factors, Treatment Options, and Addiction Reduction Strategies
11/22/2023
This summary addresses the diagnosis and risk factors of opioid use disorder, as well as the ineffectiveness of opioids as long-term pain medications, the physical manifestations and effects of opioid abuse, the need for substance use...
This summary addresses the diagnosis and risk factors of opioid use disorder, as well as the ineffectiveness of opioids as long-term pain medications, the physical manifestations and effects of opioid abuse, the need for substance use...
This summary addresses the...
11/22/2023
Pharmacy Learning Network
News
Chemical Engineers Receive $3.5 Million Grant to Investigate Adolescent Exposure and Opioid Addiction
11/20/2023
The National Institutes of Health’s National Institute on Drug Abuse is awarding a 5-year, $3.5 million grant to the Virginia Tech Department of Chemical Engineering’s pioneering research to understand how adolescent exposure may contribute...
The National Institutes of Health’s National Institute on Drug Abuse is awarding a 5-year, $3.5 million grant to the Virginia Tech Department of Chemical Engineering’s pioneering research to understand how adolescent exposure may contribute...
The National Institutes of...
11/20/2023
Pharmacy Learning Network
News
Narcan, Now Available Without a Prescription, Can Still Be Hard to Get
10/11/2023
Last month, drugstores and pharmacies nationwide began stocking and selling the country’s first over-the-counter version of naloxone, a medication that can stop a potentially fatal overdose from opioids, but it’s unclear whether the move will...
Last month, drugstores and pharmacies nationwide began stocking and selling the country’s first over-the-counter version of naloxone, a medication that can stop a potentially fatal overdose from opioids, but it’s unclear whether the move will...
Last month, drugstores and...
10/11/2023
Pharmacy Learning Network
News
Decreases in Opioid Prescribing by State Varied After CDC Guidance
10/06/2023
Understanding state-level trends and variations in opioid prescribing may help inform future efforts to improve prescribing and reduce related harm, researchers advised.
Understanding state-level trends and variations in opioid prescribing may help inform future efforts to improve prescribing and reduce related harm, researchers advised.
Understanding state-level trends...
10/06/2023
Pharmacy Learning Network
News
More Schools Stock Overdose Reversal Meds, but Others Worry About Stigma
10/03/2023
Colorado is among several states that ensure schools have access to the opioid overdose reversal medication naloxone for free or at reduced cost. But most districts hadn’t signed up by the start of the school year for a state distribution...
Colorado is among several states that ensure schools have access to the opioid overdose reversal medication naloxone for free or at reduced cost. But most districts hadn’t signed up by the start of the school year for a state distribution...
Colorado is among several states...
10/03/2023
Pharmacy Learning Network

Newsfeed

News
Methadone Access Reform Needed to Address the US Opioid Crisis
03/08/2024

Emry Lloyd

Emry Lloyd
As the overdose crisis intensifies, US federal regulations must undergo necessary revisions, ensuring access to life-saving medications and aligning with standards set by other advanced nations.
As the overdose crisis intensifies, US federal regulations must undergo necessary revisions, ensuring access to life-saving medications and aligning with standards set by other advanced nations.
As the overdose crisis...
03/08/2024
Pharmacy Learning Network
News
Navigating the Opioid Epidemic: Research Insights, the DSM-5, and the Mainstreaming Addiction Treatment Act
12/04/2023
"While opioid use disorder is on the rise across the world and has transformed into an epidemic in the US, it needs a better understanding from health care professionals and government intervention along with resources and a team-based...
"While opioid use disorder is on the rise across the world and has transformed into an epidemic in the US, it needs a better understanding from health care professionals and government intervention along with resources and a team-based...
"While opioid use disorder is on...
12/04/2023
Pharmacy Learning Network
News
Crucial Research Funding: Unveiling Strategies to Combat Widespread and Deadly Addictions in the US
11/22/2023
Sanford Burnham Prebys researchers have secured federal grants totaling almost $25 million to propel their investigations and clinical trials aimed at understanding and treating addiction.
Sanford Burnham Prebys researchers have secured federal grants totaling almost $25 million to propel their investigations and clinical trials aimed at understanding and treating addiction.
Sanford Burnham Prebys...
11/22/2023
Pharmacy Learning Network
News
Understanding the Opioid Epidemic: Diagnosis, Risk Factors, Treatment Options, and Addiction Reduction Strategies
11/22/2023
This summary addresses the diagnosis and risk factors of opioid use disorder, as well as the ineffectiveness of opioids as long-term pain medications, the physical manifestations and effects of opioid abuse, the need for substance use...
This summary addresses the diagnosis and risk factors of opioid use disorder, as well as the ineffectiveness of opioids as long-term pain medications, the physical manifestations and effects of opioid abuse, the need for substance use...
This summary addresses the...
11/22/2023
Pharmacy Learning Network
News
Chemical Engineers Receive $3.5 Million Grant to Investigate Adolescent Exposure and Opioid Addiction
11/20/2023
The National Institutes of Health’s National Institute on Drug Abuse is awarding a 5-year, $3.5 million grant to the Virginia Tech Department of Chemical Engineering’s pioneering research to understand how adolescent exposure may contribute...
The National Institutes of Health’s National Institute on Drug Abuse is awarding a 5-year, $3.5 million grant to the Virginia Tech Department of Chemical Engineering’s pioneering research to understand how adolescent exposure may contribute...
The National Institutes of...
11/20/2023
Pharmacy Learning Network
News
Narcan, Now Available Without a Prescription, Can Still Be Hard to Get
10/11/2023
Last month, drugstores and pharmacies nationwide began stocking and selling the country’s first over-the-counter version of naloxone, a medication that can stop a potentially fatal overdose from opioids, but it’s unclear whether the move will...
Last month, drugstores and pharmacies nationwide began stocking and selling the country’s first over-the-counter version of naloxone, a medication that can stop a potentially fatal overdose from opioids, but it’s unclear whether the move will...
Last month, drugstores and...
10/11/2023
Pharmacy Learning Network
News
Decreases in Opioid Prescribing by State Varied After CDC Guidance
10/06/2023
Understanding state-level trends and variations in opioid prescribing may help inform future efforts to improve prescribing and reduce related harm, researchers advised.
Understanding state-level trends and variations in opioid prescribing may help inform future efforts to improve prescribing and reduce related harm, researchers advised.
Understanding state-level trends...
10/06/2023
Pharmacy Learning Network
News
More Schools Stock Overdose Reversal Meds, but Others Worry About Stigma
10/03/2023
Colorado is among several states that ensure schools have access to the opioid overdose reversal medication naloxone for free or at reduced cost. But most districts hadn’t signed up by the start of the school year for a state distribution...
Colorado is among several states that ensure schools have access to the opioid overdose reversal medication naloxone for free or at reduced cost. But most districts hadn’t signed up by the start of the school year for a state distribution...
Colorado is among several states...
10/03/2023
Pharmacy Learning Network
News
Artificial Intelligence May Influence Whether Patients Can Get Pain Medication
09/06/2023
To contain the opioid crisis, health and law enforcement agencies have turned to technology to monitor doctor and patient prescription data, but experts have raised questions about how these systems work and worry about their accuracy and...
To contain the opioid crisis, health and law enforcement agencies have turned to technology to monitor doctor and patient prescription data, but experts have raised questions about how these systems work and worry about their accuracy and...
To contain the opioid crisis,...
09/06/2023
Pharmacy Learning Network
News
OUD Treatment Inequities Identified for Medicaid Beneficiaries With Disabilities
03/16/2023
Researchers compared opioid use disorder treatment trends among Medicaid members with vs without physical, sensory, developmental, and cognitive disabilities.
Researchers compared opioid use disorder treatment trends among Medicaid members with vs without physical, sensory, developmental, and cognitive disabilities.
Researchers compared opioid use...
03/16/2023
First Report Managed Care
News
Hypertension Tablets Recalled
11/20/2024
The Harvard Drug Group, doing business as Major Pharmaceuticals and Rugby Laboratories, is recalling 3 lots of hydralazine hydrochloride tablets. According to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report,...
The Harvard Drug Group, doing business as Major Pharmaceuticals and Rugby Laboratories, is recalling 3 lots of hydralazine hydrochloride tablets. According to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report,...
The Harvard Drug Group, doing...
11/20/2024
Pharmacy Learning Network
News
Chewable Tablets Recalled
11/20/2024
Reports of crushed and broken tablets have prompted Cipla USA Inc. to recall a single lot of lanthanum carbonate chewable tablets, according to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Reports of crushed and broken tablets have prompted Cipla USA Inc. to recall a single lot of lanthanum carbonate chewable tablets, according to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Reports of crushed and broken...
11/20/2024
Pharmacy Learning Network
News
Supplement Pulled for Hidden Drug Ingredients
11/20/2024
Trinity Gold Nutrition is recalling 150 packages of its dietary supplement Trinity Gold for containing undeclared acetaminophen, diclofenac, and phenylbutazone, according to the November 20, 2024, US Food and Drug Administration (FDA)...
Trinity Gold Nutrition is recalling 150 packages of its dietary supplement Trinity Gold for containing undeclared acetaminophen, diclofenac, and phenylbutazone, according to the November 20, 2024, US Food and Drug Administration (FDA)...
Trinity Gold Nutrition is...
11/20/2024
Pharmacy Learning Network
News
FDA Proposes Removal of Oral Phenylephrine from OTC Nasal Decongestants
11/14/2024
The US Food and Drug Administration (FDA) has announced in a new press release that it is proposing to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) products for nasal decongestant, citing a lack of effectiveness.
The US Food and Drug Administration (FDA) has announced in a new press release that it is proposing to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) products for nasal decongestant, citing a lack of effectiveness.
The US Food and Drug...
11/14/2024
Pharmacy Learning Network
News
Opioid Analgesic Recalled
11/13/2024
Dr Reddy’s Laboratories Inc. is recalling bottles of morphine sulfate extended-release tablets for failing to meet impurity/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling bottles of morphine sulfate extended-release tablets for failing to meet impurity/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
11/13/2024
Pharmacy Learning Network
News
Prescription-Strength NSAID Recalled
11/13/2024
Direct Rx is recalling prescription-strength ibuprofen for failing to meet impurity/degradation specifications during 18-month stability testing.
Direct Rx is recalling prescription-strength ibuprofen for failing to meet impurity/degradation specifications during 18-month stability testing.
Direct Rx is recalling...
11/13/2024
Pharmacy Learning Network
News
Glass Particles Prompt Class I Recall for Injection
11/13/2024
Staska Pharmaceuticals Inc. is recalling vials of ascorbic acid solution for injection for containing glass particulate matter.
Staska Pharmaceuticals Inc. is recalling vials of ascorbic acid solution for injection for containing glass particulate matter.
Staska Pharmaceuticals Inc. is...
11/13/2024
Pharmacy Learning Network
News
Tracking RSV Evolution and Treatment Resistance Through Genomic Surveillance
11/08/2024
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of...
11/08/2024
Pharmacy Learning Network
News
Impurity Prompts Two Firms to Recall Tablets
11/06/2024
Multiple lots of cinacalcet tablets from Accord Healthcare Inc. and Dr Reddy’s Laboratories have been recalled due to the presence of an N-nitroso cinacalcet impurity above the acceptable daily intake limit, with potential health consequences...
Multiple lots of cinacalcet tablets from Accord Healthcare Inc. and Dr Reddy’s Laboratories have been recalled due to the presence of an N-nitroso cinacalcet impurity above the acceptable daily intake limit, with potential health consequences...
Multiple lots of cinacalcet...
11/06/2024
Pharmacy Learning Network
News
OTC Antihistamine Recalled
11/06/2024
BLI International Inc. recalls superpotent chlorpheniramine maleate tablets with potential for serious harm.
BLI International Inc. recalls superpotent chlorpheniramine maleate tablets with potential for serious harm.
BLI International Inc. recalls...
11/06/2024
Pharmacy Learning Network

Interactive Features

Quiz
Calculating the Global Scope of OUD
12/05/2023
How many people experience opioid use disorder (OUD) globally?
How many people experience opioid use disorder (OUD) globally?
How many people experience...
12/05/2023
Pharmacy Learning Network
Quiz
True or False: Unlawful Opioid Distribution Statistics
12/01/2023
True or False: The DOJ’s Health Care Fraud Strike Force, operating since March 2007, has charged more than 5000 defendants who collectively billed federal health care programs and private insurance companies close to $28 billion.
True or False: The DOJ’s Health Care Fraud Strike Force, operating since March 2007, has charged more than 5000 defendants who collectively billed federal health care programs and private insurance companies close to $28 billion.
True or False: The DOJ’s Health...
12/01/2023
Pharmacy Learning Network
Quiz
Long-Term Pain Management With Opioids
11/22/2023
True or False: Opioids are effective long-term pain medications.
True or False: Opioids are effective long-term pain medications.
True or False: Opioids are...
11/22/2023
Pharmacy Learning Network
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
Videos
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
05/13/2020
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of...
05/13/2020
Pharmacy Learning Network
Quiz
Rates of Amyloid Pathology in MS
11/19/2024
True or False: Patients with MS have a higher rate of amyloid pathology compared to control subjects.
True or False: Patients with MS have a higher rate of amyloid pathology compared to control subjects.
True or False: Patients with MS...
11/19/2024
Pharmacy Learning Network
Quiz
Comorbidity Risk of Alzheimer Disease and MS
10/22/2024
True or False: Among patients with MS, amyloid plaque accumulation in the brain was more likely in those with a typical MS history.
True or False: Among patients with MS, amyloid plaque accumulation in the brain was more likely in those with a typical MS history.
True or False: Among patients...
10/22/2024
Pharmacy Learning Network
Quiz
FDA Approval for Alzheimer Disease Treatments
10/21/2024
True or False: Lecanemab-IRMB (Leqembi™) is the second Alzheimer drug that has affected the course of the disease successfully in phase 3, had a low side effect profile and then got full FDA approval.
True or False: Lecanemab-IRMB (Leqembi™) is the second Alzheimer drug that has affected the course of the disease successfully in phase 3, had a low side effect profile and then got full FDA approval.
True or False: Lecanemab-IRMB...
10/21/2024
Pharmacy Learning Network
Quiz
Understanding the Link Between Multiple Sclerosis and Alzheimer Disease
10/03/2024
True or False: Patients with a typical multiple sclerosis (MS) history are more likely to accumulate amyloid plaques in the brain compared to those with atypical presentations.
True or False: Patients with a typical multiple sclerosis (MS) history are more likely to accumulate amyloid plaques in the brain compared to those with atypical presentations.
True or False: Patients with a...
10/03/2024
Pharmacy Learning Network
Quiz
Differences in Alzheimer Disease Treatment Options
09/26/2024
Which significant difference between donanemab and lecanemab was mentioned in the Phase III TRAILBLAZER-ALZ 2 study?
Which significant difference between donanemab and lecanemab was mentioned in the Phase III TRAILBLAZER-ALZ 2 study?
Which significant difference...
09/26/2024
Pharmacy Learning Network
Quiz
Alzheimer Disease Treatment Terminology
09/26/2024
What does ARIA-E stand for in Alzheimer disease treatment?
What does ARIA-E stand for in Alzheimer disease treatment?
What does ARIA-E stand for in...
09/26/2024
Pharmacy Learning Network
Quiz
Hemorrhaging Incidents in Alzheimer Disease Treatment
09/20/2024
True or False: A potential side effect noted in treating Alzheimer disease with lecanemab-IRMB is amyloid-related imaging abnormality type H (ARIA-H).
True or False: A potential side effect noted in treating Alzheimer disease with lecanemab-IRMB is amyloid-related imaging abnormality type H (ARIA-H).
True or False: A potential side...
09/20/2024
Pharmacy Learning Network
Quiz
Post-Treatment Alzheimer Disease Progression
09/18/2024
True or False: Amyloid plaque levels begin to rise again within 1 year of donanemab treatment.
True or False: Amyloid plaque levels begin to rise again within 1 year of donanemab treatment.
True or False: Amyloid plaque...
09/18/2024
Pharmacy Learning Network
Quiz
Anti-Amyloid Drugs for Treating Alzheimer Disease
09/12/2024
Quiz: According to findings from the Phase III TRAILBLAZER-ALZ 2 study, upon which the FDA approval of donanemab is based, what percentage of patients were able to discontinue the drug within a year?
Quiz: According to findings from the Phase III TRAILBLAZER-ALZ 2 study, upon which the FDA approval of donanemab is based, what percentage of patients were able to discontinue the drug within a year?
Quiz: According to findings from...
09/12/2024
Pharmacy Learning Network
Quiz
Alzheimer Disease Treatment Breakthroughs
08/27/2024
True or False: Lecanemab is the first Alzheimer's drug to successfully affect the course of the disease in phase 3 trials and receive full FDA approval.
True or False: Lecanemab is the first Alzheimer's drug to successfully affect the course of the disease in phase 3 trials and receive full FDA approval.
True or False: Lecanemab is the...
08/27/2024
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
Videos
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
05/13/2020
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of...
05/13/2020
Pharmacy Learning Network
Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement